Data presented at the ASCO 2020 Virtual Scientific Program demonstrated that Keytruda was an effective treatment for patients with Hodgkin Lymphoma and side effects were tolerable.
John Kuruvilla, MD
Advertisement
Articles by John Kuruvilla, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CURE
1
Medicare to Cut Ostomy Suppliers to 6 Contracts: What Patients Need to Know
2
3 Prostate Cancer Results From ESMO 2026 Patients Should Know
3
4 Long-Term Survival Results From ESMO 2026 Patients Should Know
4
CAR T-Cell Therapy Offers Hope for Lasting Remission in Hairy Cell Leukemia
5